The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stage II colorectal cancer (CC).
 
Timothy Iveson
Honoraria - Lilly; SERVIER
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Roche; SERVIER
Travel, Accommodations, Expenses - Bayer; SERVIER
 
Alberto F. Sobrero
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck Serono; Roche; Sanofi; SERVIER
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; celgene; Lilly; Merck Serono; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche; Takeda
 
Takayuki Yoshino
Research Funding - Chugai Pharma (Inst); GlaxoSmithKline (Inst); Sanofi (Inst); Sumitomo Dainippon (Inst)
 
Ioannis Sougklakos
Consulting or Advisory Role - Roche (Inst); SERVIER (Inst)
Speakers' Bureau - Sanofi
Research Funding - Amgen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Sanofi; SERVIER; SERVIER
 
Fang-Shu Ou
No Relationships to Disclose
 
Jeffery P. Meyers
No Relationships to Disclose
 
Qian Shi
No Relationships to Disclose
 
Mark P. Saunders
Honoraria - Amgen; Eisai; Merck; Roche; SERVIER
Research Funding - SERVIER
Travel, Accommodations, Expenses - Merck; SERVIER
 
Roberto Labianca
Consulting or Advisory Role - Lilly; Merck Serono; Roche; Sanofi
Travel, Accommodations, Expenses - Merck Serono; Roche; SERVIER
 
Takeharu Yamanaka
Honoraria - Boehringer Ingelheim; Chugai Pharma; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Gilead Sciences; HUYA Bioscience International; Sysmex
Research Funding - Chugai/Roche (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ioannis Boukovinas
Employment - Pierre Fabre (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; LEO Pharma; Merck; MSD; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genesis Pharma; Ipsen; LEO Pharma; MSD; Novartis; Roche; Sanofi
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Regeneron; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pfizer; Roche
 
Niels Henrik Hollander
No Relationships to Disclose
 
Valter Torri
No Relationships to Disclose
 
Kentaro Yamazaki
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Taiho Pharmaceutical (Inst)
 
Vassilis Georgoulias
Honoraria - AstraZeneca; Novartis; Roche
Research Funding - AstraZeneca; Novartis; Pfizer
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Lilly; Merck Serono
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Servier
Research Funding - Amgen; Merck Serono
 
Andrea Harkin
No Relationships to Disclose
 
Gerardo Rosati
No Relationships to Disclose
 
James Paul
No Relationships to Disclose